Previous StoryAccording to the guidelines likely to be announced by the Securities and Exchange Board of India (Sebi) companies will have to make public any fraud committed by directors and employees, litigation against them and the impact of this on financials, reveal details about shareholders and loan agreements besides providing estimates of losses caused by natural calamities.
Next StoryIPAB has dismissed the review petition filed by Roche & OSI Pharmaceuticals against an earlier IPAB order for receiving additional documents from Mylan Laboratories in a patent battle between the pharma companies, relating to Erlotinib hydrochloride, an active ingredient for anti-cancer drug Tarceva.
